Mativ (MATV) Q1 2025 Earnings Call May 08, 2025 08:30 AM ET Company Participants Chris Kuepper - Director - IRShruti Singhal - President and CEOGreg Weitzel - CFOLars Kjellberg - Managing Director Conference Call Participants Daniel Harriman - AnalystNone - Analyst Operator Welcome to Mattev's First Quarter twenty twenty five Earnings Conference Call. On the call today from Mattev are Shruti Singhal, Chief Executive Officer Greg Weitzel, Chief Financial Officer and Chris Cooper, Director of Investor Relatio ...

Montrose Environmental Group (MEG) Q1 2025 Earnings Call May 08, 2025 08:30 AM ET Company Participants Adrianne Griffin - SVP - IR & TreasuryVijay Manthripragada - President & CEOAllan Dicks - Chief Financial OfficerTim Mulrooney - Group Head - Global ServicesChris Grenga - Equity Research Associate Conference Call Participants David Ridley-Lane - Analyst Operator Please note this event is being recorded. I would now like to turn the conference over to Adrienne Griffin, Senior Vice President, Investor Relat ...

Financial Data and Key Metrics Changes - Revenue for the quarter was $247 million, with an adjusted EBITDA of $68.8 million, reflecting a $1.9 million increase and an adjusted EBITDA margin of 27.8%, up 130 basis points sequentially [17][18] - IPv4 leasing revenue increased sequentially by 14.8% to $14.4 million and increased 42% year over year, with average revenue per IPv4 address sold rising to $0.49, a 63% increase from the beginning of the year [8][10] - Gross margin increased by 790 basis points to 44.6%, with cost of goods sold declining from $31.6 million in the first quarter of the previous year [10] Business Line Data and Key Metrics Changes - Wavelength revenues for the quarter were $7.1 million, a 14% increase year over year, with a sequential increase of 2.2% [6] - Corporate business represented 44.9% of revenues, decreasing 11.4% year over year and 2.1% sequentially, primarily due to the grooming of low-margin off-net connections [20] - NetCentric business represented 37.5% of revenues, increasing 0.7% year over year but declining 1.1% sequentially, impacted by a decline in revenue from a commercial services agreement with T-Mobile [21] Market Data and Key Metrics Changes - On-net revenue was $129.6 million, a year-over-year decrease of 6.5% but a sequential increase of $900,000 [22] - Off-net revenue was $107.3 million, a year-over-year decrease of 9.2% and a sequential decrease of 5.2% [23] - Average price per megabit for the installed base decreased sequentially by 6% to $0.20 and decreased by 25% year over year [23] Company Strategy and Development Direction - The company aims to capture 25% of the North American wavelength market within three years and anticipates achieving a minimum of $20 million in additional cost savings through Q2 2026 [7][10] - The long-term annual revenue growth rate is adjusted to 6% to 8%, with EBITDA margin expansion targeted at 50 basis points annually [14] - The company is focused on integrating the former Sprint network and legacy Cogent network into a unified network, with plans to convert Sprint facilities into Cogent data centers [26] Management's Comments on Operating Environment and Future Outlook - Management expects to return to total top-line revenue growth by mid-Q3 2025, following the completion of the grooming of undesirable revenues from Sprint contracts [15][40] - The company acknowledges increased leverage due to recent activities but remains committed to returning capital to shareholders through dividends and buybacks [14][49] - Management expressed confidence in the wavelength business, citing a rebuilt funnel of 3,433 wavelength opportunities and a target of reaching 10,000 by year-end [7][52] Other Important Information - The company repurchased approximately 100,000 shares for about $5 million under its stock buyback program, with $17.4 million remaining available [12] - Total gross debt at par was $2 billion, with a net debt of $1.8 billion, and a gross debt to EBITDA ratio of 6.69 at quarter-end [28] Q&A Session Summary Question: Changes in competition within the Waves business - Management noted that primary competitors in the wavelength market have struggled with provisioning, giving Cogent a competitive advantage [36] Question: Update on corporate revenue trends - Management indicated that undesirable revenue from Sprint has been largely purged, and they expect corporate revenue to grow by mid-Q3 2025 [40] Question: Dividend growth and milestones for returning to growth - Management stated that the board is committed to returning capital to shareholders and will evaluate the pace of deleveraging to potentially return to dividend growth [49] Question: Wavelength ARPU trends - Management expects wavelength ARPU to stabilize around $1,900 to $2,000 as the base continues to grow [60] Question: Data center monetization timing and scale - Management is actively negotiating contracts for surplus capacity and is motivated to sell as it would aid in deleveraging [62]

Xeris Biopharma Holdings (XERS) Q1 2025 Earnings Call May 08, 2025 08:30 AM ET Company Participants Allison Wey - Senior Vice President of Investor Relations & Corporate CommunicationsJohn Shannon - CEOSteve Pieper - Chief Financial OfficerMazahir Alimohamed - Biotech Equity Research AssociateJason Dorr - Associate Director Conference Call Participants David Amsellem - Sr. Research AnalystChase Knickerbocker - Senior Equity Research Analyst - Healthcare Operator Good morning. Thank you for attending today's ...

Financial Data and Key Metrics Changes - Total revenue for Q1 2025 was over $45 million, a 46% increase from $31 million in the same period last year [36][37] - Adjusted earnings per share (EPS) for Q1 2025 was $1.33, up from $1.20 in Q1 2024 [44] - Royalty revenue increased by 44% year-over-year, totaling $27.5 million in Q1 2025 [36][37] Business Line Data and Key Metrics Changes - Varonis' O2Ver reported Q1 2025 net sales of $71.3 million, nearly double the previous quarter, with a 3% royalty earned by the company [39] - Trevyr's Filspari achieved Q1 U.S. sales of $56 million, representing over 180% year-over-year growth [40] - Merck's Capaxib reported Q1 sales of $107 million, more than double the prior quarter [41] Market Data and Key Metrics Changes - The company has over $200 million in cash and investments, with no debt and access to a $125 million revolving credit facility [10] - The biopharmaceutical financing environment is challenging, leading to increased demand for royalty financing [12][13] Company Strategy and Development Direction - The company aims for profitable and compounding growth, focusing on acquiring late-stage development and commercial assets with superior risk-reward profiles [17][19] - A strategic transaction was executed to merge Pylthos Therapeutics with Channel Therapeutics, enhancing the commercialization of ZELSUVME, an FDA-approved therapy [26][27] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the trajectory of recently approved programs and the robust development stage pipeline [47] - The company anticipates a compound annual growth rate (CAGR) of 22% for long-term royalty revenue growth, supported by existing portfolio assets [20] Other Important Information - The company reaffirmed its full-year 2025 financial guidance, expecting total revenue between $180 million and $200 million [45][46] - The merger with Channel Therapeutics is expected to close between June 30 and August 30, pending SEC review [27] Q&A Session Summary Question: Current environment for special situations in biotech - Management noted an increase in special situations due to difficult financing markets, providing good opportunities for the company [51] Question: Impact of potential drug pricing policies - Management indicated that while there may be short-term disruptions, the long-term outlook remains positive for the U.S. market [59][60] Question: Investment capacity and opportunities - Management expects to invest at an above-normal pace this year due to the number of good opportunities, while maintaining diversification limits [78] Question: Launch timing for ZELSUVME - The launch is fairly independent of the merger timing, with preparations already underway for a U.S. launch this summer [86] Question: Reimbursement and access for FOLSPARI - Management expects continued momentum from CSL in securing country-by-country reimbursement approvals, which should support growth [90]

Malibu Boats (MBUU) Q3 2025 Earnings Call May 08, 2025 08:30 AM ET Company Participants Bruce Beckman - Chief Financial OfficerSteve Menneto - CEO & PresidentEric Wold - Executive Director, Equity ResearchMichael Swartz - Director & Equity ResearchRyan Williams - Senior Equity Research Associate Conference Call Participants Craig Kennison - Director of Research Operations & Senior Research AnalystMichael Albanese - Research AnalystJaime Katz - Senior Equity Analyst Operator Good morning and welcome to Malib ...

Playtika Holding (PLTK) Q1 2025 Earnings Call May 08, 2025 08:30 AM ET Company Participants Tae Lee - SVP - Corporate Finance & Investor RelationsRobert Antokol - CO-Founder, Chairman & CEOCraig Abrahams - President & CFODoug Creutz - Managing DirectorMatthew Cost - Executive Director, Equity ResearchAlbert Kim - Equity Research Associate Operator Good day, and thank you for standing by. Welcome to the Playtica Q1 twenty twenty five Earnings Call. At this time, all participants are in listen only mode. Afte ...

Perimeter Solutions (PRM) Q1 2025 Earnings Call May 08, 2025 08:30 AM ET Company Participants Seth Barker - Head of Investor Relations and VP of Financial Planning & AnalysisHaitham Khouri - CEOKyle Sable - CFO & Principal Accounting OfficerJosh Spector - Executive Director Conference Call Participants Daniel Kutz - Vice President, Equity Analyst Operator Please note this call is being recorded and I will be standing by should you need any assistance. It is now my pleasure to turn today's program over to Se ...

Marriott Vacations Worldwide (VAC) Q1 2025 Earnings Call May 08, 2025 08:30 AM ET Company Participants Neal Goldner - Vice President, Investor RelationsJohn Geller - CEO, President & DirectorJason Marino - Executive VP & CFOC. Patrick Scholes - Managing Director - Lodging & Leisure Equity ResearchDavid Katz - Managing DirectorStephen Grambling - Managing Director Conference Call Participants Benjamin Chaiken - Equity AnalystShaun Kelley - Senior Research Analyst & MD - Gaming, Lodging & Leisure Equities Ope ...

Cleveland-Cliffs (CLF) Q1 2025 Earnings Call May 08, 2025 08:30 AM ET Company Participants Lourenco Goncalves - Chairman, President & CEOCelso Goncalves - EVP and CFOAlbert Realini - Senior Equity Research AssociateBill Peterson - Equity ResearchTimna Tanners - Managing Director - Equity Research Conference Call Participants Nick Giles - Senior Research AnalystLawson Winder - AnalystAlex Hacking - Equity Research Analyst - Metals & MiningCarlos de Alba - Analyst Operator Good morning, ladies and gentlemen. ...